Presentations include ‘Uncertainty in Qualitative and Quantitative Analysis’
Accepted as a European Reference Material following peer-review, with homogeneity and short term stability studies carried out
Recognition for expertise and reputation in this field
Hub will address manufacturing, business and regulatory challenges to ensure new targeted biological medicines can be developed quickly
Award to develop novel miRNA-based assay for accurate assessment of pluripotent stem cell contamination in derived cell therapy products
LGC represented at anniversary event in Madrid
LGC operates out of 22 countries, with laboratories and centres across Europe and the US, as well as sites in Brazil, China and India.